Insulet has paid Bigfoot Biomedical $25 million for pump-based automated insulin delivery (AID) technologies and patents.
Bigfoot initially aimed to develop a pump- and pen-version of its AID system, but has narrowed its focus in recent years. The company’s prioritization of smart pen caps that pair with continuous glucose monitors created an opportunity to cash out of the pump project.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,